Drug Type Monoclonal antibody |
Synonyms NB005.1 + [1] |
Target |
Mechanism KLRG1 inhibitors(killer cell lectin like receptor G1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Immune System Diseases | Preclinical | CN | 14 Mar 2024 | |
Neoplasms | Preclinical | CN | 14 Mar 2024 |